January 23, 2024
Jardiance® (empagliflozin) Receives Authorization from Health Canada for the Treatment of Adults With Chronic Kidney Disease
December 7, 2023
Boehringer Ingelheim Canada and Community-Based Clinics Join to Revolutionize Cardiovascular Care in Ontario
No current content.